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Bohring-Opitz syndrome (BOS) is a rare congenital disorder of unknown etiology which was first described in 1999 by Bohring et al. and described 4 cases with 
characteristic features [1]. Diagnostic criteria were defined 
later based on the phenotypic manifestations. The characteristic 
features of this condition are typical facial appearance, 
microcephaly, palatal abnormalities, facial nevus flammeus, short 
stature, joint abnormalities, abnormal tone, failure to thrive, and 
severe to profound developmental delay. The patients present 
with repeated respiratory infections, feeding difficulties, and 
failure to thrive. These patients require repeated hospitalization 
and infant mortality is high. Approximately 32 cases have been 
reported worldwide. Molecular analysis, done in some patients, 
has demonstrated mutations in ASXL1 gene while mutations of 
ASXL3 gene were identified in few patients. We report a case 
of the 6-month-old male child having gastroesophageal reflux 
(GER) and clinical features of BOS.
CASE REPORT
A 6-month-old male child presented to the department with 
a chief complaint of failure to thrive and a history of recurrent 
vomiting since the age of 1 month. He was born of a third degree 
consanguineous marriage to a 24-year-old primigravida mother 
by full-term normal delivery. His birth weight was 2.8 kg. He 
was admitted to neonatal intensive care unit on day 3 of life for 
neonatal hyperbilirubinemia and hypocalcemic convulsions. At 
1 month of age, he was treated with a splint for a foot deformity. 
He had severe feeding intolerance and recurrent episodes of non-
bilious vomiting due to GER disease. The baby was repeatedly 
hospitalized for these complaints. Written informed consent was 
obtained from the parents for taking the photographs.
On clinical examination, his length was 56 cm and weight was 
2.9 kg. The weight for length z score was <−3 standard deviation 
(SD) suggestive of severe failure to thrive. Head circumference was 
38.5  cm with  a Z-score <−3 SD suggestive of microcephaly. On 
head to toe examination, dysmorphism was noted. His craniofacial 
features included microcephaly, sloping forehead, sparse hair, 
craniosynostosis, telecanthus, prominent eyes, posteriorly rotated 
ears, high-arched palate, micrognathia, and pes planus (Fig. 1). 
He had a characteristic BOS posture, i.e., shoulder being held 
externally rotated and adducted, elbows flexed, and wrists 
flexed [2]. Neurological examination revealed truncal hypotonia 
with hypertonic limbs. Ophthalmological examination was normal. 
His developmental quotient assessed by Developmental Assessment 
Scales for Indian Infants showed a motor score of 23±7 and a mental 
score of 39±2, suggestive of profound developmental delay.
On investigation, magnetic resonance imaging (MRI) brain 
showed thinned out corpus callosum and periventricular white 
matter changes. Barium swallow showed Grade 2 GER (Fig. 2). 
Hemogram revealed nutritional anemia. Serum cholesterol was 
normal, i.e., 115 mg/dl. Chromosomal analysis showed 46 XY 
which was normal. TORCH titers and metabolic screening 
were negative. Ultrasonography of the abdomen was normal. 
Confirmatory genetic mutation testing (ASXL1 gene mutation) 
was not done due to financial constraints.
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This patient was treated with antibiotics for infections. For 
GER, thickening of feeds, positioning, and proton-pump inhibitors 
were started. Vitamin supplementations were also given. Patients 
with this disorder need a multidisciplinary approach as it affects 
the individuals physically, medically, cognitively, behaviorally, 
and psychologically. Occupational therapy and physiotherapy 
were started to improve the activity of daily living and range 
of motion and to prevent contractures. The child is on regular 
follow-up and now, he is 23-month and has started gaining 
weight. His present weight is 7.61 kg and length is 75 cm (weight 
for length z score is at −3 SD). His head circumference is 40 cm 
(z  score  <−3  SD).  TThe  child  had  a  flexion  deformity  with 
limitation of movements which is improving with physiotherapy. 
Now, he is able to sit with support and has also started recognising 
parents. He is tolerating feeds well and the frequency of vomiting 
has decreased significantly.
DISCUSSION
There are approximately 32 cases of BOS reported worldwide [3]. 
Our patient has characteristic features of this syndrome and 
associated comorbidities. Molecular diagnosis, i.e., ASXL1 gene 
mutation is a confirmatory test, but it is not available at most of 
the centers, so diagnosis is mainly based on phenotypic characters 
[4]. The clinical features of this syndrome are similar to Smith–
Lemli–Opitz syndrome, desmosterolosis, and lathosterolosis 
which are disorders of cholesterol synthesis.
All the cases (100%) present with feeding difficulties, severe 
to a profound learning disability, prominent eyes, microcephaly, 
and the typical BOS posture. Our patient had all these features. 
Low hairline with thick hairs is present in around 90% of BOS 
cases and 10% of cases can have a normal hairline. In the present 
case, the patient had a normal hairline. Majority of the patients 
described in literature required gastrostomy for feeding. Our 
patient was managed with medications and appropriate feeding 
advice. Around 80–90% of cases present with intrauterine growth 
restriction, trigonocephaly, low set ears, hypotonia, and brain 
abnormalities [2]. Around 70% of patients have structural brain 
abnormalities such as ventriculomegaly, generalized atrophy 
involving the corpus callosum and brainstem, and delayed 
myelination. MRI brain of our patient showed thinned out corpus 
callosum. This was consistent with MRI brain findings in other 
patients studied by Magini et al. [2] and Visayaragawan et al. [5]. 
Contractures are common and congenital dislocations may be 
present. Cardiac and ophthalmologic manifestations are present 
in 50% of cases. Ophthalmic features include strabismus, retinal, 
and anterior chamber abnormalities and myopia.
The molecular basis of BOS was recently identified, making 
molecular diagnosis possible [3]. For almost 50% of cases that 
meet the clinical criteria for BOS, de novo frameshift and nonsense 
mutations in the ASXL1 gene have been detected. Bainbridge et al. 
identified four individuals with de novo truncation mutations in a 
related gene, ASXL3 (chromosome 18) [6]. Of note, ASXL3 is in the 
same gene family as ASXL1 and mutations in ASXL3 are known to 
be associated with a disorder that is similar to BOS. Majority of the 
reported cases are inherited sporadically, although Greenhalgh et al. 
described a brother and sister with BOS, suggesting the possibility 
of autosomal recessive inheritance or germline mosaicism [7]. 
Only 11 cases of clinically diagnosed BOS have been confirmed by 
molecular analysis of the ASXL1 gene [5,8].
The mortality in this syndrome is usually high, due to the 
presence of various infections. If the child survives the early 
childhood period, then the chance of mortality is decreased due 
to the improvement of feeding difficulties. Parental education and 
training regarding feeding and care of the child are important in 
management and outcome of a child diagnosed with BOS.
CONCLUSION
BOS is a rare and difficult to diagnose disorder. Its diagnosis 
is mainly based on the phenotypic characters. A multidisciplinary 
approach can improve the outcome of the patient as in our case.
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